Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 1651 word(s) 1651 2022-01-19 05:02:22 |
2 format correction Meta information modification 1651 2022-02-10 03:04:06 |

Video Upload Options

We provide professional Video Production Services to translate complex research into visually appealing presentations. Would you like to try it?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Kerdsin, A. Tools for Molecular Epidemiology of Streptococcus suis. Encyclopedia. Available online: https://encyclopedia.pub/entry/19298 (accessed on 17 November 2024).
Kerdsin A. Tools for Molecular Epidemiology of Streptococcus suis. Encyclopedia. Available at: https://encyclopedia.pub/entry/19298. Accessed November 17, 2024.
Kerdsin, Anusak. "Tools for Molecular Epidemiology of Streptococcus suis" Encyclopedia, https://encyclopedia.pub/entry/19298 (accessed November 17, 2024).
Kerdsin, A. (2022, February 10). Tools for Molecular Epidemiology of Streptococcus suis. In Encyclopedia. https://encyclopedia.pub/entry/19298
Kerdsin, Anusak. "Tools for Molecular Epidemiology of Streptococcus suis." Encyclopedia. Web. 10 February, 2022.
Tools for Molecular Epidemiology of Streptococcus suis
Edit

Streptococcus suis is a pathogen of pigs that can cause infections in humans who are in close contact with infected animals and/or contaminated pork-derived products, as well as those who have consumed raw pork products. Several molecular methods have been applied to investigate S. suis strain diversity and identify phylogenetic groups. Multilocus sequence typing (MLST), commonly used to differentiate between S. suis strains, has been instrumental in identifying that the species is genetically highly diverse. Recent advances in whole-genome analysis have resulted in schemes permitting the classification of S. suis populations as pathogenic or non-pathogenic, or disease-associated or non-disease associated. 

Streptococcus suis clonal complex multilocus sequence typing (MLST) PCR minimum core genome sequence typing (MCG) pathotyping

1. Introduction

Streptococcus suis is a pathogen of pigs that can cause infections in humans who are in close contact with infected animals and/or contaminated pork-derived products, as well as those who have consumed raw pork products [1]. S. suis can cause meningitis, septicemia, endocarditis, and arthritis in humans [2][3][4]. Human S. suis cases have been reported in most countries of Western Europe, North and South America, Africa, Australia, New Zealand, India, Japan, and several other East and Southeast Asian countries, particularly China, Vietnam, and Thailand [1][3][4]. Indeed, S. suis has been shown to be responsible for thousands of human cases, of which 90.2% were in Asia, 8.5% in Europe, and 1.3% in other parts of the world [4].
Previously, S. suis had been classified into 35 serotypes (serotype 1/2, and 1–34) and which were then reduced to 33 serotypes because serotypes 32 and 34 were re-classified as S. orisratti [5][6][7][8][9]. In 2013, S. suis serotypes 20, 22, 26, and 33 were proposed to be removed from the S. suis taxon [10]: serotypes 20, 22, and 26 were proposed as Streptococcus parasuis [11][12], while serotype 33 was classified as Streptococcus ruminantium [13]. Hence, currently there are 29 true S. suis serotypes. Of them, serotype 2 is the most prevalent in both human and pig infections although cases caused by serotypes 4, 5, 9, 14, 16, 21, 24, and 31 have also been reported [1][2][3][4][14][15][16][17].
Studying the population structure and the genetic diversity of S. suis is helpful to understand the epidemiology of this organism as well as reveal clones or clonal groups with an apparently increased capacity to cause disease, or which are potentially associated with particular clinical manifestations. Several molecular typing techniques have been applied to the study of S. suis genetic diversity (Table 1).
Table 1. Characteristics of the molecular epidemiological methods for the Streptococcus suis study.

Characteristic

WGS

MLST

Multiplex PCR-CC

RAPD

PCR-RFLP

MLVA

AFLP

PFGE

Ribotyping

Reproducibility

Good

Good

Good

Poor to moderate

Moderate

Good

Good

Good

Good

Discriminatory power

Excellent

High

Moderate

Moderate to good

Poor to moderate

Excellent

Excellent

Excellent

Good

Ease of use

Moderately labor-intensive

Simple to moderate labor

Simple

Simple

Simple

Simple

Moderate

Labor-intensive

Labor-intensive

Interpretation

Moderate to very complex

Simple to moderate

Simple

Moderate to complex

Simple

Simple

Complex

Moderate to complex

Moderate to complex

Cost

Very high

Moderate

Low

Low

Low

Low to moderate

Moderate

High

High

Universal applicability

Yes

Yes

Limit to some CCs

Yes

Yes

Yes

Yes

Yes

Yes

2. Multilocus Sequence Typing (MLST)

MLST is considered the gold standard to determine the structure of S. suis populations. This powerful method uses genetic variation that accumulates very slowly in housekeeping genes to investigate the genetic diversity of S. suis and its use has allowed global and long-term epidemiology. King et al. established the MLST scheme for S. suis in 2002, using seven different house-keeping genes (cpn60, dpr, recA, aroA, thrA, gki, and mutS) [18]. Since its establishment, this MLST scheme has been adopted by multiple laboratories throughout the world and used to determine the STs of S. suis strains isolated from pig and human cases of infection [1].
Thus far (28 November 2019), a total of 1245 STs have been recorded in the S. suis MLST database (https://pubmlst.org/ssuis/). This method has revealed the presence of many clonal complexes (CCs) within the S. suis population in the database. Among the different CCs identified, the most important causes of infections in human and pig have been CC1, CC16, CC20, CC25, CC28, CC94, CC104, CC233/379, and CC221/234 (Figure 1) [1][4][17][19]. Different CCs were found to be distributed in different regions of the world [1]. CC1 was found mostly in Europe, Asia (Cambodia, China, Korea, Japan, Thailand, and Vietnam), Australia, and South America (Argentina), while CC20 (ST20) was described as being important in the Netherlands [1][19][20][21][22][23]. Furthermore, ST7 (CC1), responsible for the 1998 and 2005 epidemics, was mostly present in China [1] and CC16 and CC94 were predominant in Europe, although human cases were reported in Thailand [17][19]. CC25 or CC28 were reported in North America and were also recovered in Thailand, Korea, Japan, and Australia [1][4][19][20][21][22][23]. Finally, CC104 (ST101, ST104, ST391-ST393, ST512-ST514), and CC233/379 (ST233 and ST379) were endemic to Thailand [1][19]. In North America, the structure of S. suis strains is more complicated and pathotypes are different from Europe and Asia [24]. Serotypes 1, 1/2, 2, 7, 14, and 23 as well as ST1, ST13, ST28, ST94, ST108, ST961, and ST977 have recently been described as pathogenic strains in the USA [24].
Figure 1. A goeBURST analysis of major clonal complexes of S. suis causes of infections in human and pig. CC1 is related to CC17 whereas CC17 is closely related to CC16. CC16 and CC87 are related via ST15 and ST89. CC25 and CC28 are related via ST856. Other CCs are independent.
An alternative MLST approach using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MS-MLST) has been reported to be more rapid in providing typing results than dideoxy sequencing [22]. While both MS-MLST and conventional MLST had 100% concordance in their classification of sequence types (STs), in addition to faster time-to-results, MS-MLST had lower labor requirements and per-isolate costs. MS-MLST analysis was easier to instrument when large numbers of isolates were involved [22]. However, MS-MLST requires a high initial investment in the MALDI-TOF MS equipment and software. Therefore, this approach may not be readily available to most laboratories, particularly those in developing countries.

3. Prediction of CC Using Polymerase Chain Reaction

Although informative, MLST is a high-cost and time-consuming method that is not ideal for screening large numbers of isolates. MLST is also unavailable in many laboratories in developing countries. Therefore, polymerase chain reaction (PCR)-based approaches [24][25][26][27][28] to identify the most important S. suis CCs (PCR-CC) were developed allowing for the rapid screening of a large number of isolates at a relatively modest cost (summarized in Table 2).
Table 2. PCR-predicted important clonal complexes of S. suis isolates.

Clonal Complexes

PCR Methods

Multiplex PCR

PCR of ofs Genes

PCR-Pilus-Associated Gene Profiles

RAPD

16S-23S rDNA PCR-RFLP

CC1

Yes

Yes

Yes

Yes

Yes

CC16

No

No

No

Yes

Yes

CC20 **

No

No

No

No

No

CC25

Yes

Yes *

Yes *

Yes

Yes *

CC28

Yes

Yes *

Yes *

Yes

Yes *

CC94

No

Yes *

No

No

No

CC104

Yes

Yes *

Yes

Yes

Yes *

CC233/379

Yes

No

No

Yes

Yes *

CC221/234

Yes

No

No

Yes

Yes

Note: * reveal the same profile; thus, could not be differentiated for each. ** PCR methods were not applied to CC20.

4. Whole-Genome Sequencing Approaches

WGS approaches have increasingly been used to investigate S. suis isolates, including molecular determination of serotype [29], characterization of outbreaks [30][31], evaluation of S. suis reinfection [32], and to determine the population structure of S. suis isolates of serotype 2 belonging to ST25 and ST28 [33][34], as well as of serotype 9 [35]. WGS-based bacterial typing strategies commonly use one of two approaches: SNP (sequence)-based, or MLST (allele)-based. The SNP approach compares single nucleotide differences between isolates in comparison to a reference genome and is particularly useful to determine the clonal relationship between highly similar isolates. The MLST approach is an extension of conventional 7-gene MLST that expands the range of genes to the genome scale and can be roughly divided into core-genome-based MLST (cgMLST) and whole-genome-based MLST (wgMLST). Allele-based comparisons can be conducted using analysis tools available on the internet, such as BacWGSTdb (http://bacdb.org/BacWGSTdb/) [36], pubMLST (https://pubmlst.org/ssuis/), or the Center for Genomic Epidemiology (https://cge.cbs.dtu.dk/services/MLST/) [37].
The definition of virulence in S. suis remains controversial, and WGS-based approaches have played an important role in the efforts to identify virulence markers permitting to differentiate between commensal organisms and those prone to cause disease. A comparative genome hybridization (CGH) was used to analyze 55 S. suis isolates from different serotypes, recovered from different hosts, different clinical sources, and different geographical locations [38]. Clustering of CGH data divided S. suis isolates into 2 clusters. Cluster A exclusively contained virulent CC1 isolates of serotypes 1 and 2 isolates [38]. Cluster B, on the other hand, contained mainly a more divergent and heterogeneous group of serotype 7 and 9 isolates [38]. Another study used CGH on 39 isolates of different serotypes, sources, geographic locations, isolation years, and STs. This study revealed that the S. suis strains tested could be classified into three groups of differing levels of virulence: (i) epidemic and highly virulent (E/HV group), which included ST1, ST6, ST7, and ST11 isolates; (ii) virulent (V group), containing ST81, ST13, ST56, ST87, ST308, ST54, and ST53 isolates; and (iii) intermediately or weakly virulent (I/WV group), composed of isolates belonging to several STs that were all recovered from non-human sources [39].
The genomes of 375 S. suis isolates with detailed clinical phenotypes from pigs and humans from the United Kingdom and Vietnam were analyzed using a Bayesian Analysis of Population Structure (BAPS) [40]. The study showed clear genetic differences between systemic, respiratory, and non-clinical (carriage) S. suis isolates. Interestingly, systemic isolates had a smaller genome than respiratory and carriage isolates, and they tended to have an over-representation of virulence factors and a larger number of genes involved in defense functions [40]. Willemse et al. (2016) used BAPS to investigate the whole genomes of 98 S. suis isolates from human patients and pigs with invasive disease in the Netherlands, and 18 genomic complete and available S. suis sequences. The BAPS-based population grouping did not correlate with serotype but correlated well with the CC of the isolates. BAPS Group 1 comprised all CC13 isolates, BAPS Group 2 comprised most of the CC16 isolates, BAPS Group 4 comprised all CC1 isolates, BAPS Group 5 comprised both the CC27 and the CC29 isolates, and BAPS Group 6 comprised most CC20 isolates [41].

References

  1. Goyette-Desjardins, G.; Auger, J.-P.; Xu, J.; Segura, M.; Gottschalk, M. Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing. Emerg. Microbes. Infect. 2014, 3, e45.
  2. Hlebowicz, M.; Jakubowski, P.; Smiatacz, T. Streptococcus suis Meningitis: Epidemiology, Clinical Presentation and Treatment. Vector Borne Zoonotic Dis. 2019, 19, 557–562.
  3. Huong, V.T.L.; Ha, N.; Huy, N.T.; Horby, P.; Nghia, H.D.T.; Thiem, V.D.; Zhu, X.; Hoa, N.T.; Hien, T.T.; Zamora, J.; et al. Epidemiology, Clinical manifestations, and outcomes of Streptococcus suis infection in Humans. Emerg. Infect. Dis. 2014, 20, 1105–1114.
  4. Dutkiewicz, J.; Sroka, J.; Zając, V.; Wasiński, B.; Cisak, E.; Sawczyn, A.; Kloc, A.; Wójcik-Fatla, A. Streptococcus suis: A re-emerging pathogen associated with occupational exposure to pigs or pork products. Part I—Epidemiology. Ann. Agric. Environ. Med. 2017, 24, 683–695.
  5. Gottschalk, M.; Higgins, R.; Jacques, M.; Mittal, K.R.; Henrichsen, J. Description of 14 new capsular types of Streptococcus suis. J. Clin. Microbiol. 1989, 27, 2633–2636.
  6. Gottschalk, M.; Higgins, R.; Jacques, M.; Beaudoin, M.; Henrichsen, J. Characterization of six new capsular types (23 through 28) of Streptococcus suis. J. Clin. Microbiol. 1991, 29, 2590–2594.
  7. Gottschalk, M.; Higgins, R.; Jacques, M.; Beaudoin, M.; Henrichsen, J. Isolation and characterization of Streptococcus suis capsular types 9–22. J. Vet. Diagn. Investig. 1991, 3, 60–65.
  8. Higgins, R.; Gottschalk, M.; Boudreau, M.; Lebrun, A.; Henrichsen, J. Description of Six New Capsular Types (29–34) of Streptococcus Suis. J. Vet. Diagn. Investig. 1995, 7, 405–406.
  9. Hill, J.E.; Gottschalk, M.; Brousseau, R.; Harel, J.; Hemmingsen, S.M.; Goh, S.H. Biochemical analysis, cpn60 and 16S rDNA sequence data indicate that Streptococcus suis serotypes 32 and 34, isolated from pigs, are Streptococcus orisratti. Vet. Microbiol. 2005, 107, 63–69.
  10. Tien, L.H.T.; Nishibori, T.; Nishitani, Y.; Nomoto, R.; Osawa, R. Reappraisal of the taxonomy of Streptococcus suis serotypes 20, 22, 26, and 33 based on DNA–DNA homology and sodA and recN phylogenies. Vet. Microbiol. 2013, 162, 842–849.
  11. Nomoto, R.; Maruyama, F.; Ishida, S.; Tohya, M.; Sekizaki, T.; Osawa, R. Reappraisal of the taxonomy of Streptococcus suis serotypes 20, 22 and 26: Streptococcus parasuis sp. Int. J. Syst. Evol. Microbiol. 2015, 65, 438–443.
  12. Okura, M.; Osaki, M.; Nomoto, R.; Arai, S.; Osawa, R.; Sekizaki, T.; Takamatsu, D. Current Taxonomical Situation of Streptococcus suis. Pathogens 2016, 5, 45.
  13. Tohya, M.; Arai, S.; Tomida, J.; Watanabe, T.; Kawamura, Y.; Katsumi, M.; Ushimizu, M.; Ishida-Kuroki, K.; Yoshizumi, M.; Uzawa, Y.; et al. Defining the taxonomic status of Streptococcus suis serotype 33: The proposal for Streptococcus ruminantium sp. nov. Int. J. Syst. Evol. Microbiol. 2017, 67, 3660–3665.
  14. Hatrongjit, R.; Kerdsin, A.; Gottschalk, M.; Takeuchi, D.; Hamada, S.; Oishi, K.; Akeda, Y. First human case report of sepsis due to infection with Streptococcus suis serotype 31 in Thailand. BMC Infect. Dis. 2015, 15, 392.
  15. Kerdsin, A.; Oishi, K.; Sripakdee, S.; Boonkerd, N.; Polwichai, P.; Nakamura, S.; Uchida, R.; Sawanpanyalert, P.; Dejsirilert, S. Clonal dissemination of Streptococcus suis serotype 14 in Thailand. J. Med. Microbiol. 2009, 58, 1508–1513.
  16. Kerdsin, A.; Dejsirilert, S.; Sawanpanyalert, P.; Boonnark, A.; Noithachang, W.; Sriyakum, D.; Simkum, S.; Chokngam, S.; Gottschalk, M.; Akeda, Y.; et al. Sepsis and spontaneous bacterial peritonitis in Thailand. Lancet 2011, 378, 960. Available online: https://doi.org/10.1016/S0140-6736(11)60923-9 (accessed on 27 January 2020).
  17. Kerdsin, A.; Hatrongjit, R.; Gottschalk, M.; Takeuchi, D.; Hamada, S.; Akeda, Y.; Oishi, K. Emergence of Streptococcus suis serotype 9 infection in humans. J. Microbiol. Immunol. Infect. 2017, 50, 545–546.
  18. King, S.J.; Leigh, J.A.; Heath, P.J.; Luque, I.; Tarradas, C.; Dowson, C.G.; Whatmore, A.M. Development of a Multilocus Sequence Typing Scheme for the Pig Pathogen Streptococcus suis: Identification of Virulent Clones and Potential Capsular Serotype Exchange. J. Clin. Microbiol. 2002, 40, 3671–3680.
  19. Kerdsin, A.; Akeda, Y.; Takeuchi, D.; Dejsirilert, S.; Gottschalk, M.; Oishi, K. Genotypic diversity of Streptococcus suis strains isolated from humans in Thailand. Eur. J. Clin. Microbiol. Infect. Dis. 2018, 37, 917–925.
  20. Oh, S.-I.; Jeon, A.B.; Jung, B.-Y.; Byun, J.-W.; Gottschalk, M.; Kim, A.; Kim, J.W.; Kim, H.-Y. Capsular serotypes, virulence-associated genes and antimicrobial susceptibility of Streptococcus suis isolates from pigs in Korea. J. Vet. Med. Sci. 2017, 79, 780–787.
  21. Schultsz, C.; Jansen, E.; Keijzers, W.; Rothkamp, A.; Duim, B.; Wagenaar, J.A.; Van Der Ende, A. Differences in the Population Structure of Invasive Streptococcus suis Strains Isolated from Pigs and from Humans in the Netherlands. PLoS ONE 2012, 7, e33854.
  22. Groves, M.D.; Jordan, D.; Chapman, T.A.; Al Jassim, R. Multilocus sequence typing of Australian Streptococcus suis type 2 by MALDI-TOF mass spectrometry analysis of PCR amplicons. Vet. Microbiol. 2015, 177, 394–397.
  23. Oh, Y.; Tark, D.; Moon, S.-H.; Han, J.-I.; Kim, W.-I.; Cho, H.-S. Sepsis Caused by Streptococcus suis Serotype 2 in a Eurasian River Otter (Lutra lutra) in the Republic of Korea. J. Wildl. Dis. 2018, 54, 866–869.
  24. Estrada, A.A.; Gottschalk, M.; Rossow, S.; Rendahl, A.; Gebhart, C.; Marthaler, D.G. Serotype and Genotype (Multilocus Sequence Type) of Streptococcus suis Isolates from the United States Serve as Predictors of Pathotype. J. Clin. Microbiol. 2019, 57, e00377-19.
  25. Takamatsu, D.; Osaki, M.; Tharavichitkul, P.; Takai, S.; Sekizaki, T. Allelic variation and prevalence of serum opacity factor among the Streptococcus suis population. J. Med. Microbiol. 2008, 57, 488–494.
  26. Takamatsu, D.; Nishino, H.; Ishiji, T.; Ishii, J.; Osaki, M.; Fittipaldi, N.; Gottschalk, M.; Tharavichitkul, P.; Takai, S.; Sekizaki, T. Genetic organization and preferential distribution of putative pilus gene clusters in Streptococcus suis. Vet. Microbiol. 2009, 138, 132–139.
  27. Hatrongjit, R.; Kerdsin, A.; Gottschalk, M.; Hamada, S.; Oishi, K.; Akeda, Y. Development of a multiplex PCR assay to detect the major clonal complexes of Streptococcus suis relevant to human infection. J. Med. Microbiol. 2016, 65, 392–396.
  28. Maneerat, K.; Yongkiettrakul, S.; Kramomtong, I.; Tongtawe, P.; Tapchaisri, P.; Luangsuk, P.; Chaicumpa, W.; Gottschalk, M.; Srimanote, P. Virulence Genes and Genetic Diversity ofStreptococcus suisSerotype 2 Isolates from Thailand. Transbound. Emerg. Dis. 2013, 60, 69–79.
  29. Athey, T.B.T.; Teatero, S.; Lacouture, S.; Takamatsu, D.; Gottschalk, M.; Fittipaldi, N. Determining Streptococcus suis serotype from short-read whole-genome sequencing data. BMC Microbiol. 2016, 16, 162.
  30. Huang, W.; Wang, M.; Hao, H.; Yang, R.; Xie, J.; Su, J.; Lin, M.; Cui, Y.; Jiang, Y. Genomic epidemiological investigation of a Streptococcus suis outbreak in Guangxi, China, 2016. Infect. Genet. Evol. 2019, 68, 249–252.
  31. Du, P.; Zheng, H.; Zhou, J.; Lan, R.; Ye, C.; Jing, H.; Jin, D.; Cui, Z.; Bai, X.; Liang, J.; et al. Detection of Multiple Parallel Transmission Outbreak of Streptococcus suis Human Infection by Use of Genome Epidemiology, China, 2005. Emerg. Infect Dis. 2017, 23, 204–211.
  32. Willemse, N.; van der Ende, A.; Schultsz, C. Reinfection with Streptococcus suis analysed by whole genome sequencing. Zoonoses Public Health 2019, 66, 179–183.
  33. Athey, T.B.; Teatero, S.; Takamatsu, D.; Wasserscheid, J.; Dewar, K.; Gottschalk, M.; Fittipaldi, N. Population Structure and Antimicrobial Resistance Profiles of Streptococcus suis Serotype 2 Sequence Type 25 Strains. PLoS ONE 2016, 11, e0150908.
  34. Athey, T.B.T.; Auger, J.-P.; Teatero, S.; Dumesnil, A.; Takamatsu, D.; Wasserscheid, J.; Dewar, K.; Gottschalk, M.; Fittipaldi, N. Complex Population Structure and Virulence Differences among Serotype 2 Streptococcus suis Strains Belonging to Sequence Type 28. PLoS ONE 2015, 10, e0137760.
  35. Zheng, H.; Du, P.; Qiu, X.; Kerdsin, A.; Roy, D.; Bai, X.; Xu, J.; Vela, A.I.; Gottschalk, M. Genomic comparisons of Streptococcus suis serotype 9 strains recovered from diseased pigs in Spain and Canada. Vet. Res. 2018, 49, 1.
  36. Ruan, Z.; Feng, Y. BacWGSTdb, a database for genotyping and source tracking bacterial pathogens. Nucleic Acids Res. 2016, 44, D682–D687.
  37. Larsen, M.V.; Cosentino, S.; Rasmussen, S.; Friis, C.; Hasman, H.; Marvig, R.L.; Jelsbak, L.; Sicheritz-Pontén, T.; Ussery, D.W.; Aarestrup, F.M.; et al. Multilocus Sequence Typing of Total-Genome-Sequenced Bacteria. J. Clin. Microbiol. 2012, 50, 1355–1361.
  38. De Greeff, A.; Wisselink, H.J.; De Bree, F.M.; Schultsz, C.; Baums, C.G.; Thi, H.N.; Stockhofe-Zurwieden, N.; Smith, H.E. Genetic diversity of Streptococcus suis isolates as determined by comparative genome hybridization. BMC Microbiol. 2011, 11, 161.
  39. Zheng, H.; Lan, R.; Zheng, X.; Cui, Z.; Liu, Z.; Bai, X.; Ji, S.; Gottschalk, M.; Xu, J. Comparative Genomic Hybridization Identifies Virulence Differences in Streptococcus suis. PLoS ONE 2014, 9, e87866.
  40. Weinert, L.A.; Chaudhuri, R.R.; Wang, J.; Peters, S.E.; Corander, J.; Jombart, T.; Baig, A.; Howell, K.J.; Vehkala, M.; Välimäki, N.; et al. Genomic signatures of human and animal disease in the zoonotic pathogen Streptococcus suis. Nat. Commun. 2015, 6, 6740. Available online: https://doi.org/10.1038/ncomms7740 (accessed on 27 January 2020).
  41. Willemse, N.; Howell, K.J.; Weinert, L.A.; Heuvelink, A.; Pannekoek, Y.; Wagenaar, J.A.; Smith, H.E.; Van Der Ende, A.; Schultsz, C. An emerging zoonotic clone in the Netherlands provides clues to virulence and zoonotic potential of Streptococcus suis. Sci. Rep. 2016, 6, 28984.
More
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 415
Revisions: 2 times (View History)
Update Date: 10 Feb 2022
1000/1000
ScholarVision Creations